Ondine Biomedical Inc. NPV (CDI) (OBI) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Jul 2025 10:21 AM
RNS
Steriwave in Half of Fraser Health Hospitals
01 Jul 2025 07:00 AM
RNS
Ondine Appoints Peel Hunt as Broker
30 Jun 2025 07:00 AM
RNS
Leading Canadian Surgery Centre Adopts Steriwave
26 Jun 2025 06:02 PM
RNS
Result of AGM and voting results
25 Jun 2025 07:00 AM
RNS
Steriwave Standard of Care in 2nd Health Authority
19 Jun 2025 07:00 AM
RNS
Second Quebec Hospital Adopts Steriwave
16 Jun 2025 07:00 AM
RNS
UK Doctor Wins Award for NHS Steriwave Innovation
12 Jun 2025 07:00 AM
RNS
NHS Trust up for HSJ Award for Steriwave Use
10 Jun 2025 07:29 AM
RNS
Ondine Presents Groundbreaking Findings
10 Jun 2025 07:00 AM
RNS
Exercise of Options
09 Jun 2025 07:00 AM
RNS
UCL Shows Steriwave Effective Against Mucor Fungus
05 Jun 2025 07:00 AM
RNS
Canada's Largest Cardiac Centre Adopts Steriwave
04 Jun 2025 07:00 AM
RNS
Notice of AGM
15 May 2025 07:00 AM
RNS
2024 Full Year Results and Annual Report
12 May 2025 07:00 AM
RNS
Ondine Joins CAN Health Network
09 May 2025 07:00 AM
RNS
Appointment of non-Board Interim CFO
08 May 2025 07:00 AM
RNS
Notice of Results and Investor Presentation
09 Apr 2025 07:00 AM
RNS
Economic study suggests c.£200 million UK savings
08 Apr 2025 05:00 PM
RNS
Replacement: Steriwave in first Swiss hospital
08 Apr 2025 07:00 AM
RNS
Steriwave in first Swiss hospital
02 Apr 2025 07:00 AM
RNS
Mid Yorkshire NHS Trust cuts SSI rates by 71%
28 Mar 2025 03:00 PM
RNS
Board Changes
19 Mar 2025 07:00 AM
RNS
Steriwave enters ICU and related Issue of Shares
17 Mar 2025 07:00 AM
RNS
Quebec Hospital Cuts Spine SSIs by 78%
14 Mar 2025 07:00 AM
RNS
Exercise of Options
26 Feb 2025 08:00 AM
RNS
Grant of Options
26 Feb 2025 07:00 AM
RNS
Seasoned MedTech Exec Appointed as CFO & COO
19 Feb 2025 07:00 AM
RNS
Nasal photodisinfection US market potential
06 Feb 2025 11:00 AM
RNS
Ondine President increases shareholding
04 Feb 2025 08:30 AM
RNS
Ondine CEO increases shareholding
03 Feb 2025 08:00 AM
RNS
Ondine CEO increases ownership
03 Feb 2025 07:00 AM
RNS
Appointment of Nominated and Financial Adviser
31 Jan 2025 10:03 AM
RNS
CEO Increases Stake in Ondine
31 Jan 2025 09:52 AM
RNS
Replacement: Director Increases Stake in Ondine
31 Jan 2025 07:00 AM
RNS
Director Increases Stake in Ondine
30 Jan 2025 05:49 PM
RNS
Notification of Major Holdings
29 Jan 2025 05:00 PM
RNS
Notification of Major Holdings
29 Jan 2025 07:15 AM
RNS
Grant of Options and Warrants
27 Jan 2025 07:00 AM
RNS
HCA to invest US$4 million in Ondine
30 Dec 2024 07:00 AM
RNS
Ondine recruits first patient for US Phase 3 trial
17 Dec 2024 07:00 AM
RNS
Ondine commencing US Phase 3 clinical trial
25 Nov 2024 05:00 PM
RNS
Notification of Major Holdings
22 Nov 2024 10:31 AM
RNS
Notification of Major Holdings
22 Nov 2024 08:30 AM
RNS
Director Holdings
18 Nov 2024 05:00 PM
RNS
NOTIFICATION OF MAJOR HOLDINGS
15 Nov 2024 03:30 PM
RNS
Final Result of Fundraise & TVR
14 Nov 2024 07:00 AM
RNS
Updated Result of Fundraise
11 Nov 2024 07:00 AM
RNS
Update on Private Placement and Placing
01 Nov 2024 03:34 PM
RNS
Result of Fundraise
01 Nov 2024 07:00 AM
RNS
Proposed Fundraise

Ondine Biomedical is a Canadian life sciences company that develops light-activated antimicrobial therapies called photodisinfection to prevent and treat infections, including those from drug-resistant bacteria.

It is listed on LSE under the ticker OBI.

OBI share price launched at 59p in 2021.

UK 100

Latest directors dealings